Effects of pH, electric current, and enzyme inhibitors on iontophoresis of delta sleep-inducing peptide

被引:11
|
作者
Chiang, CH [1 ]
Shao, CH [1 ]
Chen, JL [1 ]
机构
[1] Sch Pharm, Natl Def Med Ctr, Taipei 100, Taiwan
关键词
D O I
10.3109/03639049809085640
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Delta sleep-inducing peptide (DSIP), a peptide of nine amino acid residues, was used as a model drug to investigate the effects of pH, electric current, and enzyme inhibitors on the transdermal iontophoretic delivery of peptide drugs. DSIP was fairly stable in pH 4-9 buffer solutions but was cleaved by the skin enzymes during iontophoretic delivery. Enzyme inhibitors, such as o-phenanthroline, ethylene-diaminetetraacetic acid (EDTA), dilucine, and sodium deoxycholate, could inhibit the degradation of DSIP to a certain extent in the skin homogenate. Our results showed that metalloproteases were probably more important enzymes for DSIP hydrolysis. By using 0.2 mM o-phenanthroline in the iontophoretic delivery of DSIP at pH 4, we were able to significantly enhance the penetration of DSIP. The flux was about eight times as much as control (without o-phenanthroline) at pH 7.4.
引用
收藏
页码:431 / 438
页数:8
相关论文
共 50 条
  • [41] Interaction of Delta Sleep-inducing Peptide and Valproate on Metaphit Audiogenic Seizure Model in Rats
    Olivera Stanojlović
    Dragan Hrnčić
    Aleksandra Rašić
    Helena Lončar-Stevanović
    Dragan Djuric
    Veselinka Šušić
    Cellular and Molecular Neurobiology, 2007, 27 : 923 - 932
  • [42] Interaction of delta sleep-inducing peptide and valproate on metaphit audiogenic seizure model in rats
    Stanojlovic, Olivera
    Hrncic, Dragan
    Rasic, Aleksandra
    Loncar-Stevanovic, Helena
    Djuric, Dragan
    Susic, Veselinka
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2007, 27 (07) : 923 - 932
  • [43] PRODUCTION AND IMMUNOHISTOCHEMICAL APPLICATION OF MONOCLONAL-ANTIBODIES AGAINST DELTA SLEEP-INDUCING PEPTIDE
    CHARNAY, Y
    GOLAZ, J
    VALLET, PG
    BOURAS, C
    JOURNAL OF CHEMICAL NEUROANATOMY, 1992, 5 (06) : 503 - 509
  • [44] INVITRO CHARACTERIZATION OF BLOOD-BRAIN-BARRIER PERMEABILITY TO DELTA SLEEP-INDUCING PEPTIDE
    RAEISSI, S
    AUDUS, KL
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (12) : 848 - 852
  • [46] Distribution of delta sleep-inducing peptide in the newborn and infant human hypothalamus: an immunohistochemical study
    Najimi, M
    Bennis, M
    Moyse, E
    Chigr, F
    BIOLOGICAL RESEARCH, 2001, 34 (01) : 31 - 42
  • [47] DEGRADATION AND AGGREGATION OF DELTA SLEEP-INDUCING PEPTIDE (DSIP) AND 2 ANALOGS IN PLASMA AND SERUM
    GRAF, MV
    SAEGESSER, B
    SCHOENENBERGER, GA
    PEPTIDES, 1987, 8 (04) : 599 - 603
  • [48] Solution structure of porcine delta sleep-inducing peptide immunoreactive peptide a homolog of the shortsighted gene product
    Seidel, G
    Adermann, K
    Schindler, T
    Ejchart, A
    Jaenicke, R
    Forssmann, WG
    Rösch, P
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) : 30918 - 30927
  • [49] Delta sleep-inducing peptide and its tetrapeptide analogue alleviate severity of metaphit seizures
    Stanojlovic, O
    Zivanovic, D
    Mirkovic, S
    Mikhaleva, I
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2004, 77 (02) : 227 - 234
  • [50] SLEEP-PROMOTING EFFECT OF THE SLEEP-PROMOTING SUBSTANCE (SPS) AND DELTA SLEEP-INDUCING PEPTIDE (DSIP) IN THE MOUSE
    NAGASAKI, H
    KITAHAMA, K
    VALATX, JL
    JOUVET, M
    BRAIN RESEARCH, 1980, 192 (01) : 276 - 280